About Us
Success Stories
Articles
FAQ
Contact Us

Our Services
Our Locations
Rescue Studies
Accell Oncology

Select Page

Accell Oncology Business Development Unit at ASCO Annual Meeting 2022

by bd@accellclinical.com | Jun 22, 2022 | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Search for:

Recent Comments

Archives

Categories

No categories

Meta

Log in
Entries feed
Comments feed
WordPress.org

Company News

November 10, 2023

Accell at Medidata NEXT New York 2023: Mapping the Future of Clinical Research

Accell’s team recently attended an industry-leading event, Medidata NEXT New York 2023 conference, held on November 7-8 in the heart of Midtown Manhattan.

April 3, 2023

Accell has launched new challenging projects

Accell’s team is enthusiastic to announce that it is about to start two new Phase III studies in oncology and ophthalmology.

Events

CPHI Frankfurt 2022

Meet Accell’s team at the biggest pharma industry event of 2022 – CPHI Frankfurt, held at Messe Frankfurt, Frankfurt, Germany on November 1-3, 2022.

2022 ASCO Annual Meeting

Learn numerous advantages of running an oncology clinical trial in Eastern Europe from Accell’s team, your trusted CRO partner.

Immuno-Oncology 360°

On February 26-28, 2020 Natalia Nayanova, Accell’s Founder and Managing Member, attended the annual conference “Immuno-Oncology 360°” held in Crowne Plaza Times Square in New York City.

Accell Clinical Research, LLC is an International Contract Research Organization (CRO) supporting innovation with superior clinical trial services in Europe and the Eurasian Economic Union for over a decade.

Facebook


Careers
Privacy Notice
Site Map

X

We are here when you need us.
Get in touch and let’s start something great together.

First Name *

Company Name *

Last Name *

Your E-mail *

What Is Your Indication?

Tell Us Your Phase

* required fields

Sign Up for Accell’s Newsletter